Lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) patients diagnosed with lung cancer; (2) age 18 to 65 years old, gender not limited; (3) to understand the purpose of testing, voluntary participation and sign a consent form.
Exclusion criteria
Exclusion criteria: (1) to the study of pharmaceutical ingredients known allergies; (2) the tumor of lung cancer patients, patients with HIV positive; (3) the experiment is contraindicated in patients with severe chronic diseases; (4) the liver function damage, SGPT and SGOT 3 times greater than the upper limit of normal value; (5) the abnormal renal function, serum creatinine (Cr) 1.5 times greater than the upper limit of normal; (6) with severe systemic disease, such as cardiovascular, respiratory, digestive, nervous, endocrine, urogenital system diseases, etc.) and the condition is not stable; (7) have a pregnancy (at the first visit by urine pregnancy test to determine), ready for pregnancy during the tests are lactating women; (8) has a history of drug abuse or alcohol; (9) within 30 days before the test for other drug clinical trial; (10) the researchers determine patient adherence is poor, could not finish my study in accordance with the requirements; (11) have a brain, bone metastases, a large number of patients with pleural effusion. Pain, is not competent for treatment of patients; (12) treatment 2 weeks still obvious gastrointestinal reaction, reaction of chemotherapy patients with very obvious.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IgA;IgM;IgE;NIF;interleukin;CD6;CD8;CD6/CD8; | — |
Secondary
| Measure | Time frame |
|---|---|
| Tumor markers; | — |
Countries
China